PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 71.10
+4.20 (6.28%)
Oct 31, 2025, 1:30 PM CST
PharmaEngine Revenue
PharmaEngine had revenue of 196.79M TWD in the quarter ending June 30, 2025, a decrease of -24.86%. This brings the company's revenue in the last twelve months to 2.48B, up 188.62% year-over-year. In the year 2024, PharmaEngine had annual revenue of 2.52B with 228.70% growth.
Revenue (ttm)
2.48B
Revenue Growth
+188.62%
P/S Ratio
4.12
Revenue / Employee
56.39M
Employees
44
Market Cap
10.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 1.76B | 228.70% |
| Dec 31, 2023 | 767.67M | 113.29M | 17.31% |
| Dec 31, 2022 | 654.38M | -452.00K | -0.07% |
| Dec 31, 2021 | 654.84M | -401.18M | -37.99% |
| Dec 31, 2020 | 1.06B | 741.97M | 236.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |